Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study

Autor: Fischer, Matthias, Moreno, Lucas, Ziegler, David S, Marshall, Lynley V, Zwaan, C Michel, Irwin, Meredith S, Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K, Branle, Fabrice, Geoerger, Birgit, Schulte, Johannes H ^*

Publikováno v: In The Lancet Oncology December 2021 22(12):1764-1776

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 1 of Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

Autor: Seifert, Georg, Blakeslee, Sarah B., Calaminus, Gabriele, Kandil, Farid I., Barth, Andrea, Bernig, Toralf, Classen, Carl Friedrich, Corbacioglu, Selim, Föll, Jürgen, Gottschling, Sven, Gruhn, Bernd, vom Hoff-Heise, Claudia, Lode, Holger N., Martin, David, Nathrath, Michaela, Neunhoeffer, Felix, Pekrun, Arnulf, Wulff, Beate, Zuzak, Tycho, Henze, Günter, Längler, Alfred

Additional file 1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92dbebdde7db2c13d606fbe76e23207b

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Autor: Halton, Jacqueline, Brandão, Leonardo R, Luciani, Matteo, Bomgaars, Lisa, Chalmers, Elizabeth, Mitchell, Lesley G, Nurmeev, Ildar, Sharathkumar, Anjali, Svirin, Pavel, Gorbatikov, Kirill, Tartakovsky, Igor, Simetzberger, Monika, Huang, Fenglei, Sun, Zhichao, Kreuzer, Jörg, Gropper, Savion, Reilly, Paul, Brueckmann, Martina, Albisetti, Manuela, Nurmeev, Ildar, Safina, Asiya, Zapletal, Ondrej, Brandão, Leonardo R, Kuhn, Tomas, Votava, Tomas, Felgenhauer, Judy, Sharathkumar, Anjali, Svirin, Pavel, Amid, Ali, Halton, Jacqueline, Gorbatikov, Kirill, Saracco, Paola, Kiss, Csongor, Halimeh, Susan, Reschke, Madlen, Wulff, Beate, David, Michele, Novak, Zbynek, Trunina, Inna, Albisetti, Manuela, Frisk, Tony, Glosli, Heidi, Groll, Andreas, Lvova, Olga, Sasmaz, Ilgen, Sosothikul, Darintr, Zilinskaite, Virginija, Cockrell, Erin, Digtyar, Valeriy, Hadacova, Ivana, Palmu, Sauli, Pawar, Anjali, Annichino Bizzacchi, Joyce Maria, Caliskan, Umran, Celkan, Tiraje, Dmytriiev, Dmytro, Druzgal, Colleen Harkins, Onelda Elena, Graciela, Kattamis, Antonis, Kavakli, Ramazan Kaan, Male, Christoph, Ozdemir, Nihal, Van Damme, An, Zvereva, Tatiana, Aarli, Aanen, Paredes Aguilera, Rogelio Alejandro, Aytac, Selin, Carneiro, Jorge, Chistolini, Antonio, Mazzucconi, Maria Gabriela, Corrales-Medina, Fernando, Couturaud, Francis, Croteau, Stacey E, Trenor III, Cameron, Damgaard, Michael, Dixon, Natalia, Galustyan, Anna, Hak, Jiri, Hoffmann, Marianne, Kupesiz, Alphan, Labarque, Veerle, van Geet, Christel, Lin, Ming-Chih, Fu, Yun-Ching, Loggetto, Sandra, Mondelaers, Veerle, Odri-Komazec, Irena, Revel-Vilk, Shoshana, Sevilla, Julian, Fuzzato Silva, Luciano, Kerr Saraiva, José, Montes Tapia, Fernando Felix, Woods-Swafford, Wendy

Publikováno v: The Lancet Haematology; January 2021, Vol. 8 Issue: 1 pe22-e33, 12p

2007 4 Week therapy with the non-nucleosidic polymerase inhibitor bi207127 in combination with peginterferon-alfa2a and ribavirin in treatment naive and treatment experienced chronic HCV GT1 patients

Autor: Larrey, D., Lohse, A., de Ledinghen, V., Trepo, C., Gerlach, T., Zarski, J.-P., Tran, A., Mathurin, P., Thimme, R., Arastéh, K., Trautwein, C., Cerny, A., Dikopoulos, N., Schuchmann, M., Heim, M.H., Gerken, Guido, Stern, J., Wu, K., Abdallah, N., Girlich, B., Josepf, S., Wulff, Beate, Berger, F., Steffgen, J., BI207127 Study Group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3dfc0dc72557ff39cb458125a7dad90